Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
The stock trailed the S&P 500, which registered a daily gain of 0.28%. Meanwhile, the Dow experienced a rise of 0.15%, and the technology-dominated Nasdaq saw an increase of 0.15%. Coming into today, shares of the vaccine maker had gained 7.67% in the past month. In that same time, the Medical sector gained 0.38%, while the S&P 500 gained 2%. The upcoming earnings release of Novavax will be of great interest to investors. The company's upcoming EPS is projected at -$0.91, signifying a 27.78% increase compared to the same quarter of the previous year. Our most recent consensus estimate is calling for quarterly revenue of $52.32 million, down 72.02% from the year-ago period. For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of -$1.04 per share and a revenue of $739.47 million, representing changes of +80.78% and -24.83%, respectively, from the prior year. Investors should also note any recent changes to analyst estimates for Novavax. These recent
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- Free COVID-19 tests are now available. Here's how you can get them. [USA TODAY]USA TODAY
- COVID cases are on a downward trend. How long will this last? [USA TODAY]USA TODAY
- Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & DevelopmentPR Newswire
- Health Canada approves Pfizer's updated COVID-19 vaccine, manufacturer says [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Florida's New Guidance For COVID-19 Vaccines Stokes Fears Instead Of Saving Lives [Forbes]Forbes
NVAX
Earnings
- 8/8/24 - Miss
NVAX
Sec Filings
- 9/18/24 - Form 144
- 8/21/24 - Form 4
- 8/20/24 - Form 4
- NVAX's page on the SEC website